If you look at this https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00182-1/fulltext
Well than China is 4%, Japan is 4%, UK is 9%, USA is whopping 57%
So not sure why the US is so high compared to other countries and why those countries are so low.
According to this, the US accounts for more than half of recent cancer funding, with China and Japan just under 5%
That is so odd I wonder if the reason the US spends so much more money on cancer research is because the lobbyist is so much more massive in the US the pharmaceutical companies and universities are so massive in the US and are lobbying the government to spend money on cancer research.
Where those other countries only have a handful of pharmaceutical companies and universities unlike the US that has hundreds of pharmaceutical companies and universities.
But again some one could ask why those countries have only handful of pharmaceutical companies and universities?
Well than China is 4%, Japan is 4%, UK is 9%, USA is whopping 57%
So not sure why the US is so high compared to other countries and why those countries are so low.
According to this, the US accounts for more than half of recent cancer funding, with China and Japan just under 5%
![ascopost.com](https://ascopost.com/media/14020506/tap-logo-meta.png)
Global Funding for Cancer Research: 2016–2020
In a study reported in The Lancet Oncology, McIntosh et al identified components of global funding for cancer research—both public and philanthropic—between 2016 and 2020.
ascopost.com
That is so odd I wonder if the reason the US spends so much more money on cancer research is because the lobbyist is so much more massive in the US the pharmaceutical companies and universities are so massive in the US and are lobbying the government to spend money on cancer research.
Where those other countries only have a handful of pharmaceutical companies and universities unlike the US that has hundreds of pharmaceutical companies and universities.
But again some one could ask why those countries have only handful of pharmaceutical companies and universities?